Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes
- PMID: 20039218
- DOI: 10.1245/s10434-009-0863-0
Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes
Abstract
Background: The purpose of this study was to evaluate the impact of the negative lymph node (NLN) count on the prognostic prediction of the ratio between positive and examined lymph nodes (RML) in gastric cancer after curative resection.
Methods: The positive and negative node counts were determined for 456 patients who underwent curative resection for gastric cancer. Overall survival was examined according to clinicopathologic variables. The correlation between the NLN count and the aforementioned best variable for prediction the disease-specific overall survival was examined.
Results: The NLN count cutoffs were designed as 0-9, 10-14, and > or =15, with the 5-year survival rate 4.1, 30.7, and 74.8%, respectively. RML of 98 patients who had an NLN count of nine or fewer was > or =40%. The median survival of these patients was 12 months. Of 88 patients who had 10 to 14 NLN count, 7 had 74-month median survival with 0.1-10% RML, 52 had 47-month median survival with 10.1-40% RML, and 29 had 22-month median survival with >40% RML. Of 270 patients who had > or =15 NLN count, 157 had 114-month median survival without positive nodes, 62 had 98-month median survival with 0.1-10% RML, 45 had 40-month median survival with 10.1-40% RML, and 6 had 14-month median survival with >40% RML.
Conclusions: The NLN count is a key factor for improvement of survival prediction of RML in gastric cancer.
Similar articles
-
The prognostic analysis of lymph node-positive gastric cancer patients following curative resection.J Surg Res. 2010 Jun 1;161(1):47-53. doi: 10.1016/j.jss.2008.12.019. Epub 2009 Jan 10. J Surg Res. 2010. PMID: 19783008
-
The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer.Int J Surg. 2013;11(5):419-24. doi: 10.1016/j.ijsu.2013.03.009. Epub 2013 Mar 27. Int J Surg. 2013. PMID: 23541652
-
Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.Ann Surg Oncol. 2009 Feb;16(2):319-26. doi: 10.1245/s10434-008-0240-4. Epub 2008 Dec 3. Ann Surg Oncol. 2009. PMID: 19050970
-
Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.Eur J Surg Oncol. 2009 Aug;35(8):814-9. doi: 10.1016/j.ejso.2008.11.007. Epub 2008 Dec 25. Eur J Surg Oncol. 2009. PMID: 19111430
-
Multivariate prognostic study on large gastric cancer.J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631. J Surg Oncol. 2007. PMID: 17582596 Review.
Cited by
-
Preliminary study of surgical audit for overall survival following gastric cancer resection.Gastric Cancer. 2015 Jan;18(1):138-46. doi: 10.1007/s10120-014-0343-5. Epub 2014 Feb 6. Gastric Cancer. 2015. PMID: 24500678
-
A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer.Cancer Commun (Lond). 2018 May 15;38(1):23. doi: 10.1186/s40880-018-0293-0. Cancer Commun (Lond). 2018. PMID: 29764518 Free PMC article.
-
Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy.Oncotarget. 2017 Apr 26;8(41):71197-71205. doi: 10.18632/oncotarget.17430. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050356 Free PMC article.
-
Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.Ann Transl Med. 2020 Sep;8(17):1075. doi: 10.21037/atm-20-1358a. Ann Transl Med. 2020. PMID: 33145294 Free PMC article.
-
Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer.Transl Cancer Res. 2020 Dec;9(12):7450-7457. doi: 10.21037/tcr-20-2351. Transl Cancer Res. 2020. PMID: 35117345 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical